"Visitation restrictions are currently in place to decrease possible exposure to Coronavirus (COVID-19). Please visit our website for more information. CHI Health Lakeside is dedicated to delivering high quality, compassionate care to Omaha and nearby communities. Visit us at 16901 Lakeside Hills Ct or call (402) 717-8000 for more information."

During the past decade, Alegent Health Lakeside Hospital conducted 142 clinical trials. In the 10-year time frame, 142 clinical trials started and 101 clinical trials were completed, i.e. on average, 71.1% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 64 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alegent Health Lakeside Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 108 trials, followed by "Alliance for Clinical Trials in Oncology" with 38 trials sponsored, "SWOG Cancer Research Network" with 36 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "NRG Oncology" with 21 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alegent Health Lakeside Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 120 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Alegent Health Lakeside Hospital" are "Breast Cancer" (14 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Colorectal Cancer" (7 trials). Many other conditions were trialed in "Alegent Health Lakeside Hospital" in a lesser frequency.

Most popular intervention types in "Alegent Health Lakeside Hospital" are "Drug" (183 trials), "Other" (134 trials), "Biological" (100 trials), "Procedure" (55 trials) and "Radiation" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "Quality-of-Life Assessment" (50 trials), "Computed Tomography" (30 trials), "Questionnaire Administration" (29 trials) and "Nivolumab" (28 trials). Other intervention names were less common.

The vast majority of trials in "Alegent Health Lakeside Hospital" are 183 trials for "All" genders, 38 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Alegent Health Lakeside Hospital". undefined are not yet recruiting, 55 are recruiting, 109 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Alegent Health Lakeside Hospital, 2 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Alegent Health Lakeside Hospital, 10 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 113 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Alegent Health Lakeside Hospital has several departments that took part in Clinical trials: "Nebraska Heart Institute- Grand Island" - 6 trials, "Bergan Cardiology" - 2 trials